0001437749-18-001305.txt : 20180129
0001437749-18-001305.hdr.sgml : 20180129
20180129185645
ACCESSION NUMBER: 0001437749-18-001305
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180125
FILED AS OF DATE: 20180129
DATE AS OF CHANGE: 20180129
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cohen Daniel L
CENTRAL INDEX KEY: 0001672300
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36913
FILM NUMBER: 18557155
MAIL ADDRESS:
STREET 1: 2656 CROSSPARK ROAD, SUITE 100
CITY: CORALVILLE
STATE: IA
ZIP: 52241
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: KEMPHARM, INC
CENTRAL INDEX KEY: 0001434647
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 205894398
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2500 CROSSPARK ROAD, SUITE E126
CITY: CORALVILLE
STATE: IA
ZIP: 52241
BUSINESS PHONE: 319-665-2575
MAIL ADDRESS:
STREET 1: 2500 CROSSPARK ROAD, SUITE E126
CITY: CORALVILLE
STATE: IA
ZIP: 52241
FORMER COMPANY:
FORMER CONFORMED NAME: KEMPHARM INC
DATE OF NAME CHANGE: 20080507
4
1
rdgdoc.xml
FORM 4
X0306
4
2018-01-25
0001434647
KEMPHARM, INC
KMPH
0001672300
Cohen Daniel L
C/O KEMPHARM, INC.
2500 CROSSPARK ROAD, SUITE E126
CORALVILLE
IA
52241
1
EVP, Govt. & Public Relations
Stock Option (right to buy)
5.50
2018-01-25
4
A
0
75000
0
A
2028-01-24
Common Stock
75000
75000
D
Grant to the Reporting Person of a stock option under the Issuer's 2014 Equity Incentive Plan (the "Plan"). 25% of the shares will vest on January 25, 2019 and the remaining 75% of the shares will vest in equal annual installments thereafter, provided that at the relevant vesting dates such optionee's employment relationship has not been terminated as defined in the Plan. All shares underlying the option will vest in full and become immediately exercisable upon a change of control of the Issuer or if the Reporting Person is terminated without cause or resigns for good reason. The option expires ten years after the date of grant.
/s/ Timothy J. Sangiovanni, Attorney-in-Fact for Daniel L. Cohen
2018-01-29